Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
294.00
-4.20
(-1.41%)
At close: March 5 at 7:07:17 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 19 | 18 | 27 | 28 |
| Avg. Estimate | 8.05B | 8.87B | 35.19B | 35.87B |
| Low Estimate | 7.71B | 8.66B | 34.62B | 34.48B |
| High Estimate | 8.46B | 9.16B | 35.92B | 38.64B |
| Year Ago Sales | 7.45B | 8.39B | 33.42B | 35.19B |
| Sales Growth (year/est) | 8.14% | 5.74% | 5.29% | 1.92% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| AMG.F | -- | -- | -- | -- |
| S&P 500 | 16.04% | 7.30% | 10.63% | 14.23% |
Upgrades & Downgrades
| Maintains | B of A Securities: Underperform to Underperform | 3/5/2025 |
| Maintains | Piper Sandler: Overweight to Overweight | 2/10/2025 |
| Maintains | B of A Securities: Underperform to Underperform | 2/6/2025 |
| Maintains | Citigroup: Neutral to Neutral | 1/28/2025 |
| Reiterates | RBC Capital: Outperform to Outperform | 1/24/2025 |
| Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 1/10/2025 |
Related Tickers
AZN.L AstraZeneca PLC
12,062.00
-0.02%
GRFS Grifols, S.A.
8.71
+5.32%
SAN.PA Sanofi
108.80
-0.46%
ROG.SW Roche Holding AG
303.20
-0.33%
BAYN.DE Bayer Aktiengesellschaft
24.49
+4.12%
AZN AstraZeneca PLC
77.96
+0.92%
NVO Novo Nordisk A/S
90.86
+3.84%
MRK Merck & Co., Inc.
93.19
+0.68%
GILD Gilead Sciences, Inc.
115.44
+0.61%
LLY Eli Lilly and Company
929.72
+2.05%